piracetam has been researched along with Action Myoclonus-Renal Failure Syndrome in 5 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Zhang, N | 1 |
| Liu, C | 1 |
| Shi, M | 1 |
| Sun, L | 1 |
| Hamada, S | 1 |
| Shimakawa, S | 1 |
| Satomura, S | 1 |
| Naito, E | 1 |
| Hashimoto, T | 1 |
| Kobayashi, K | 1 |
| Takeuchi, A | 1 |
| Oka, M | 1 |
| Akiyama, M | 1 |
| Ohtsuka, Y | 1 |
| Kinrions, P | 1 |
| Ibrahim, N | 1 |
| Murphy, K | 1 |
| Lehesjoki, AE | 1 |
| Järvela, I | 1 |
| Delanty, N | 1 |
| Hirose, M | 1 |
| Yokoyama, H | 1 |
| Noguchi, R | 1 |
| Haginoya, K | 1 |
| Aoki, M | 1 |
| Iinuma, K | 1 |
5 other studies available for piracetam and Action Myoclonus-Renal Failure Syndrome
| Article | Year |
|---|---|
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroence | 2018 |
[Successful treatment of epilepsy and circadian rhythm disturbance with levetiracetam in a patient with dentatorubral-pallidoluysian atrophy (DRPLA)].
Topics: Anticonvulsants; Circadian Rhythm; Electroencephalography; Humans; Levetiracetam; Male; Myoclonic Ep | 2014 |
Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
Topics: Adolescent; Anticonvulsants; Epilepsies, Myoclonic; Humans; Levetiracetam; Male; Myoclonic Epilepsie | 2012 |
Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy.
Topics: Adult; Amino Acid Substitution; Anticonvulsants; Chromosomes, Human, Pair 21; Cystatin B; Cystatins; | 2003 |
[Improvement of action myoclonus in a patient with dentatorubral-pallidoluysian atrophy by piracetam].
Topics: Adolescent; Cerebral Cortex; Female; Humans; Myoclonic Epilepsies, Progressive; Neuroprotective Agen | 2004 |